Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorTianjin Medical University
About this trial
To evaluate the potential usefulness of 18F-FPyCO/SMBT-1 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various MAO-B-related disease patients.
Eligibility criteria
Qualifiers
None
Disqualifiers
patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.
Trial design
Treatments tested in this trial
- Diagnostic Test: 18F-FPyCO/SMBT-1
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Tianjin Medical University
Lead sponsor
Tianjin Medical University General Hospital
Collaborator
Source ClinicalTrials.gov